SRPT
NASDAQ · Biotechnology
Sarepta Therapeutics Inc
$20.48
+0.34 (+1.69%)
Analyst Consensus
Hold
33
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+94.3% upside
Low Target
$34.71
Average Target
$39.80
High Target
$61.57
Current Price
$20.48
Current
$20.48
$20.48
Target
$39.80
$39.80
$34.71
$39.80 avg
$61.57
Scenario Analysis
Bear Case
$34.71
69.5%
Low target
Base Case
$39.80
+94.3%
Avg target
Bull Case
$61.57
+200.6%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$25.32
-19.1% from high
52-Week Low
$14.68
+39.5% from low
Target vs 52W High
$39.80
+57.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |